Elevance Health Q3 2026 net income rises 13% year over year to $1.34 billion
ELV•Elevance Health’s third-quarter 2026 net income rose 13% year over year to $1.34 billion. Revenue increased to $50.44 billion, while the company’s full-year outlook calls for diluted earnings of at least $22 per share.
1. Quarterly results
Third-quarter diluted earnings rose 18% year over year to $6.27 per share, and operating revenue increased to $50.44 billion, supported by higher premium yields, CarelonRx product revenue and service fees. Health Benefits operating gain fell 27% to $436 million, reflecting targeted investments supporting its long-term operating model.
2. Full-year outlook
Elevance Health’s 2026 outlook calls for diluted earnings of at least $22 per share.
